Caleco Pharma
Caleco Pharma Corp. is a new pharmaceutical company focused on the ongoing research and development of its pipeline of over-the-counter and prescription medications including its proprietary antiviral and “Liver Health” OTC formulations. In addition, Caleco is developing Dermatological Products based on the active ingredients found in its proprietary formulation. Caleco’s intellectual property covering the Liver Health formulations and derivatives consists of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
The company's mission is to develop and secure partnership out-licensing opportunities based on fast-track drug development programs for unique and proprietary ethical pharmaceutical products that maximize the value of Caleco Pharma intellectual property patents, while developing and maximizing revenue streams based on the commercialization of in-licensed pharmaceutical products, clinical diagnostics, and natural plant-based complementary and alternative medicine products.
Caleco’s shares are traded in the United States on the OTC Bulletin Board (OTCBB:CAEH) and in Germany on the Frankfurt Stock Exchange (FRANKFURT:T3R)(WKN:A0N9Y0).